相关实验视频
Updated: May 24, 2025

08:05
Design and Analysis for Fall Detection System Simplification
Published on: April 6, 2020
10.6K
在高血压患者中使用 thiazide 利尿剂和跌倒和昏睡的风险:一项回顾性队列研究
M Yogesh1, Mohil Karangia2, Jay Nagda1
1Department of Community Medicine, Shri M P Shah Government Medical College, Jamnagar, India.
The Indian journal of medical research
|March 4, 2025
概括
用于高血压的化物利尿剂增加了患者跌倒和昏睡的风险. 这种风险与电解质失衡和脏问题有关,需要仔细监测患者.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 老年病的医生 老年病的医生
背景情况:
- 铁酸性利尿剂是常见的高血压治疗方法.
- 它们与昏迷和跌倒的风险增加有关.
研究的目的:
- 为了研究 thiazide 利尿剂使用与高血压患者的跌倒或昏睡之间的关联.
主要方法:
- 回顾性队列研究 (2019年3月至2024年3月).
- 236名接受 thiazide 治疗的高血压患者与236名对照患者相比.
- 电子医疗记录数据提取.
- 用于风险因素分析的物流回归.
主要成果:
- thiazide 组的低血,低血,高血症,代谢性,急性损伤和慢性病的发病率更高.
- 在 thiazide 组中,跌倒/同的患病率明显高 (32.2%对19.5%).
- 多变量分析确定年龄,心力衰竭, thiazide 持续时间,电解质障碍和功能障碍是危险因素.
结论:
- 在高血压患者中使用 thiazide 利尿剂与昏迷和跌倒的增加有关.
- 电解质障碍和功能障碍可能会影响这种风险.
- 强调需要对服用 thiazide 的患者进行仔细监测和个性化治疗计划.
相关概念视频
Antihypertensive Drugs: Thiazide-Class Diuretics
512
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
512
Heart Failure Drugs: Diuretics
324
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
324
Antihypertensive Drugs: Action of Diuretics
610
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
610
Antihypertensive Drugs: Potassium-Sparing Diuretics
433
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
433
Alterations in Blood Pressure
1.2K
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
1.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
363
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
363

